A team researchers in the University of Florida Clinical and Translational Science Institute received a combined $1.25 million award from the National Institutes of Health toward a goal of translating research into improved health for patients. Among them, Julie A. Johnson, Pharm.D., the V.
A University of Florida genetics researcher has received $10.6 million to further a national effort to use genetic data to more effectively pinpoint which medications and treatments are best for individual patients. Julie A. Johnson, Pharm.D., the V. Ravi Chandran Professor in Pharmaceutical Sciences and chair of pharmacotherapy and translational research in the College of Pharmacy, is one of 14 researchers who have received a five-year award as part of the National Institute of Health’s Pharmacogenomics Research Network.
